HR 2700 · 116th Congress 2019โ€“2021, ended

Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act

Latest action · Jun 26, 2019 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 14, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act

This bill addresses prescription drugs and extends several health care, research, and workforce programs.

Currently, a generic drug manufacturer is awarded 180 days of exclusivity on the market if it is the first applicant to file an application with the Food and Drug Administration (FDA), and the exclusivity period begins upon the first applicant's commercial marketing. The bill authorizes the FDA to approve a subsequent generic drug application prior to the first applicant's first date of commercial marketing if certain conditions are met.

The bill prohibits a brand-name, generic, or biosimilar drug manufacturer from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement, with specified exclusions, is a violation of the bill if the filer of the subsequent generic application receives something of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biological product.

The developer of a drug or biological product, such as a generic or biosimilar version of a drug, may bring a civil action against the license holder of an approved drug if the holder has declined to make available sufficient quantities of the approved drug for the developer's testing.

The bill also extends several health care, research, and workforce programs, including the National Health Service Corps, through FY2020.

Cosponsors 44

Members who signed on, in the order they did. Signatures ran from May 14, 2019 to Dec 5, 2019; 29 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-ILAdam KinzingerOriginalMay 14, 2019
R-TXBill FloresOriginalMay 14, 2019
R-OHBill JohnsonOriginalMay 14, 2019
R-MOBilly LongOriginalMay 14, 2019
R-KYBrett GuthrieOriginalMay 14, 2019
R-WACathy McMorris RodgersOriginalMay 14, 2019
R-WVDavid B. McKinleyOriginalMay 14, 2019
R-GADoug CollinsOriginalMay 14, 2019
R-GAEarl L. "Buddy" CarterOriginalMay 14, 2019
R-WIF. James Sensenbrenner, Jr.OriginalMay 14, 2019
R-MIFred UptonOriginalMay 14, 2019
R-MTGreg GianforteOriginalMay 14, 2019
R-ORGreg WaldenOriginalMay 14, 2019
R-FLGus M. BilirakisOriginalMay 14, 2019
R-VAH. Morgan GriffithOriginalMay 14, 2019

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

Actions 5

Everything that happened, newest first.

  1. Jun 26, 2019Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
  2. Jun 26, 2019Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
  3. May 15, 2019Referred to the Subcommittee on Health.
  4. May 14, 2019Introduced in House
  5. May 14, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 3

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H4013Mike Bost R-ILMay 21, 2019
HouseDebate and remarks H3856, H3857Michael C. Burgess R-TXMay 16, 2019
HouseDebate and remarks H3804Michael C. Burgess R-TXMay 15, 2019

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section I, Clause 1 of the U.S. Constitution, in that the legislation concerns the exercise of legislative powers generally granted to Congress, including the exercise of those powers when delegated by Congress to the Executive. Article I, Section 8, Clause 3 of the U.S. Constitution in that the legislation exercises legislative powers granted to Congress by that clause ``to regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes.''

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 80, May 14, 2019, page H3790.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 116-40INVESTING IN AMERICA'S HEALTHCARE294 pagesEnergy and Commerce CommitteeJun 4, 2019

CRS reports 2

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 2

Products on other subjects that cite it, usually among other measures.

Related bills 11

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 19Lower Costs, More Cures Act of 2019Related billDec 19, 2019
S 192Community and Public Health Programs Extension ActRelated billJan 18, 2019
S 340CREATES Act of 2019Related billFeb 6, 2019
HR 938BLOCKING Act of 2019Related billMay 2, 2019
HR 965CREATES Act of 2019Related billMay 16, 2019

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To incentivize low-cost drug options and generic competition, and to provide extensions for community health centers and the National Health Service Corps, and for other purposes.
Short Title(s) as Introduced
Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 14, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.